1. Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers
    Belinda J Cridge et al, 2013, Oncology Discovery CrossRef
  2. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy
    Rama I. Mahran et al, 2017, The AAPS Journal CrossRef
  3. Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma
    Stefanie Kewitz et al, 2013, Cancer Growth and Metastasis CrossRef
  4. Curcumin inhibits the replication of enterovirus 71 in vitro
    Ying Qin et al, 2014, Acta Pharmaceutica Sinica B CrossRef
  5. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells
    Jade Dhananjay Dasiram et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  6. Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer
    Sebastien Taurin et al, 2013, Journal of Drug Targeting CrossRef
  7. Protective effect of curcumin against heavy metals-induced liver damage
    Wylly Ramsés García-Niño et al, 2014, Food and Chemical Toxicology CrossRef
  8. Cadmium‐induced toxicity is rescued by curcumin: A review
    Mohammad Mohajeri et al, 2017, BioFactors CrossRef
  9. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
    BABASAHEB YADAV et al, 2012, International Journal of Oncology CrossRef
  10. Utility of the second-generation curcumin analogue RL71 in canine histiocytic sarcoma
    Barnaby Kelly et al, 2024, Veterinary Research Communications CrossRef
  11. Pculin02H, a curcumin derivative, inhibits proliferation and clinical drug resistance of HER2-overexpressing cancer cells
    Jin-Cherng Lien et al, 2015, Chemico-Biological Interactions CrossRef
  12. Small-molecule RL71-triggered excessive autophagic cell death as a potential therapeutic strategy in triple-negative breast cancer
    Jian Gao et al, 2017, Cell Death & Disease CrossRef
  13. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer
    Shuli Chen et al, 2017, International Journal of Oncology CrossRef
  14. Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview
    Abigail L. Flint et al, 2022, Molecules CrossRef
  15. The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells
    Barnaby Kelly et al, 2023, Veterinary and Comparative Oncology CrossRef
  16. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models
    Snehal Nirgude et al, 2020, Molecules CrossRef
  17. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer
    Bryant W. Megna et al, 2017, Journal of Surgical Research CrossRef
  18. Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin – An in vitro and in silico approach
    Kumaravel Mohankumar et al, 2014, Chemico-Biological Interactions CrossRef
  19. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
    SEBASTIEN TAURIN et al, 2016, International Journal of Oncology CrossRef
  20. Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer
    Baofang Yang et al, 2015, Oncotarget CrossRef